Logo

IOL Chemicals and Pharmaceuticals Share Price

NSE: IOLCP
|
Pharmaceuticals
₹ 142.96
-₹7.35 (-4.89%)
1D
Last updated 03 Jul, 2026, 15:57 IST

IOL Chemicals and Pharmaceuticals Share Price Today

As of 5 Jul 2026, IOL Chemicals and Pharmaceuticals share price is ₹142.96. The stock opened at ₹150.70, compared to its previous close of ₹150.31. During today's trading session, IOL Chemicals and Pharmaceuticals share price moved in the range of ₹140.27 to ₹150.89, with an average price of ₹145.58 for the day. Looking at its last 52-week, the stock has touched a low of ₹67.19 and a high of ₹151.20. On the performance front, IOL Chemicals and Pharmaceuticals share price has increased by 70.13% over the last six months and is up 53.05% on a year-on-year basis.

₹140.27
4.89% down today
₹150.89
1D LOW
1D HIGH

IOL Chemicals and Pharmaceuticals Returns Calculator

Open
₹150.70
High
₹150.89
Low
₹140.27
Prev. close
₹150.31
Circuit
L
H
₹114.37
₹171.55
52-week
L
H
₹67.19
₹151.20

IOL Chemicals and Pharmaceuticals Shareholder Returns

IOL Chemicals and Pharmaceuticals Share Price History

Mkt Cap Cr
4,408.78
P/E
32.03
P/B
2.45
ROE
7.65%
D/E
0.08
ROCE
10.29%
Div. Yield
0.67%
EPS(TTM)
4.69
Turnover
1.22
EV/EBITDA
15.25
Net Margin
0.00%
Op. Margin
0.00%
ROA
5.32%
Quick Ratio
0.00
Curr. Ratio
2.20
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
IOL Chemicals outperforming all market indices
Step 1 of 5
Valuation
Overvalued
IOL Chemicals appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
IOL Chemicals revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

IOL Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,079.21₹2,132.79₹2,217.11₹2,184.02
Other Income₹22.41₹30.07₹25.61₹32.04
Total Revenue₹2,101.62₹2,162.86₹2,242.72₹2,216.06
Total Expenses₹1,963.66₹1,981.21₹2,054.07₹1,977.28
Profit Before Tax₹137.96₹181.65₹188.65₹224.85
Tax₹36.89₹47.22₹49.51₹57.18
Profit After Tax₹101.07₹134.43₹139.14₹167.67
EPS - Basic₹3.44₹4.58₹23.70₹28.56
EPS - Diluted₹3.44₹4.58₹23.70₹28.56

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹137.96₹181.65₹188.65₹224.85
Income before WC changes₹217.81₹241.47₹233.06₹257.97
Change in Assets₹25.18-₹71.66₹41.30-₹285.53
Change in Liabilities-₹46.05₹161.99-₹104.99₹183.19
Change in WC-₹20.87₹90.33-₹63.69-₹102.34
Cash flow from Operations₹178.62₹289.78₹122.27₹93.05
Cash flow from Investing-₹154.18-₹190.98-₹120.00-₹120.52
Cash flow from Financing₹46.04-₹92.50-₹4.11-₹1.64
Total Cash Flow₹70.48₹6.30-₹1.84-₹29.11
Cash (Start of the year)₹7.69₹1.39₹3.23₹32.34
Cash (End of the year)₹78.17₹7.69₹1.39₹3.23

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,230.73₹1,124.63₹1,101.74₹881.48
Current Assets₹1,151.34₹1,119.77₹920.39₹1,080.82
Total Assets₹2,382.07₹2,244.40₹2,022.13₹1,962.30
Current Liabilities₹609.91₹560.00₹456.26₹513.40
Net Current Asset₹541.43₹559.77₹464.13₹567.42
Non-Current Liabilities₹84.50₹72.89₹58.15₹56.62
Equity Capital₹1,687.66₹1,611.51₹1,507.72₹1,392.28
Total Equity & Liabilities₹2,382.07₹2,244.40₹2,022.13₹1,962.30

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,079.21₹2,132.79₹2,217.11₹2,184.02
Other Income₹22.40₹30.07₹25.57₹32.04
Total Revenue₹2,101.61₹2,162.86₹2,242.68₹2,216.06
Total Expenses₹1,963.72₹1,980.22₹2,053.19₹1,979.29
Profit Before Tax₹137.89₹182.64₹189.49₹222.84
Tax₹36.89₹47.22₹49.51₹57.18
Profit After Tax₹101.00₹135.42₹139.98₹165.66
EPS - Basic₹3.44₹4.61₹23.84₹28.22
EPS - Diluted₹3.44₹4.61₹23.84₹28.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹137.89₹182.64₹189.49₹222.84
Income before WC changes₹217.67₹242.40₹233.91₹255.96
Change in Assets₹25.18-₹71.90₹41.67-₹285.53
Change in Liabilities-₹45.85₹161.98-₹105.34₹183.19
Change in WC-₹20.67₹90.08-₹63.67-₹102.34
Cash flow from Operations₹178.68₹290.46₹123.14₹91.04
Cash flow from Investing-₹154.23-₹191.39-₹119.19-₹120.62
Cash flow from Financing₹46.04-₹92.50-₹4.11-₹1.64
Total Cash Flow₹70.49₹6.57-₹0.16-₹31.22
Cash (Start of the year)₹7.53₹0.96₹1.12₹32.34
Cash (End of the year)₹78.02₹7.53₹0.96₹1.12

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,230.66₹1,124.49₹1,101.54₹881.58
Current Assets₹1,151.12₹1,119.48₹919.07₹1,078.71
Total Assets₹2,381.78₹2,243.97₹2,020.61₹1,960.29
Current Liabilities₹609.87₹559.75₹455.91₹513.40
Net Current Asset₹541.25₹559.73₹463.16₹565.31
Non-Current Liabilities₹84.50₹72.89₹58.15₹56.62
Equity Capital₹1,687.41₹1,611.33₹1,506.55₹1,390.27
Total Equity & Liabilities₹2,381.78₹2,243.97₹2,020.61₹1,960.29
* All values are in INR Crore
Qty
Bid
2114
142.96
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 2114
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
61.94
Neutral
ATR (14)
7.27
Neutral
STOCH(9,6)
62.51
Neutral
STOCH RSI (14)
45.27
Neutral
ADX(9)
39.25
Bearish
UO(9)
49.87
Neutral
ROC(12)
13.41
Bullish
WillR(14)
-29.43
Neutral
Period
Simple value
Exponential vaue
5D
145.62
143.94
10D
138.68
140.29
20D
134.14
135.01
50D
119.42
121.2
100D
97.79
107.74

About IOL Chemicals and Pharmaceuticals

IOL Chemicals and Pharmaceuticals logo
ISIN
INE485C01029
Sector Market Cap
₹ 4,408.78 Cr

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.

IOL Chemicals and Pharmaceuticals Financial Highlights

  • Revenue: IOL Chemicals and Pharmaceuticals reported revenue of ₹2,340.44 crore in FY26 vs ₹2,101.62 crore in FY25. It showed an increase of 11.36% on a yearly basis.
  • Operating Profit: IOL Chemicals and Pharmaceuticals reported an operating profit of ₹184.36 crore in FY26 vs ₹137.96 crore in FY25. It showed an increase of 33.63% on a year-on-year basis.
  • Net Profit: IOL Chemicals and Pharmaceuticals reported a net profit of ₹137.64 crore in FY26 vs ₹101.07 crore in FY25. It showed an increase of 36.18% on a yearly basis.

IOL Chemicals and Pharmaceuticals Quarterly Result Highlights

  • IOL Chemicals and Pharmaceuticals reported revenue of ₹621.29 crore in Mar 2026, compared with ₹585.68 crore in Dec 2025, representing an increase of 6.08% on a quarter-on-quarter (QoQ) basis.
  • IOL Chemicals and Pharmaceuticals reported an operating profit of ₹70.81 crore in Mar 2026, compared with ₹27.55 crore in Dec 2025, representing an increase of 157.02% on a quarter-on-quarter (QoQ) basis.
  • IOL Chemicals and Pharmaceuticals reported a profit of ₹53.16 crore in Mar 2026, compared with ₹20.58 crore in Dec 2025, reflecting an increase of 158.31% on a QoQ basis.
  • The earnings per share (EPS) of IOL Chemicals and Pharmaceuticals stood at ₹3.44 during Mar 2026.
Know more
Promoters
57.48%
FII
1.72%
Other DII
0.00%
Retail and other
40.78%
Mutual funds
0.02%
Foreign institutions - FII
Compare against other stocks
IOL Chemicals and Pharmaceuticals logo
IOL Chemicals and Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

FAQs on IOL Chemicals and Pharmaceuticals Share Price